ArticleObesity (Silver Spring, Md.)2026
Protecting CEACAM1 Expression Prevents Diet-Induced Metabolic Dysfunction and Hepatic Fibrosis in Male Mice.
Article in Obesity (Silver Spring, Md.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
objectiveHigh-fat diet represses Ceacam1 transcription via a PPARα-mediated mechanism to cause insulin resistance before inflammation develops. The current study investigated whether mutating PPRE-RXRα in Ceacam1 promoter prevents diet-induced metabolic abnormalities and hepatic fibrosis in male C57BL6/J mice.
methodsA knock-in mouse line (KI) bearing mutation on PPRE-RXRα in Ceacam1 promoter was generated. Male mice were fed with regular chow, high-fat diet, or GAN diet for 1-4 months before insulin action was assessed in vivo by hyperinsulinemia-euglycemia clamp analysis and energy balance was analyzed by indirect calorimetry. H&E and Sirius Red staining were carried out to detect steatohepatitis and hepatic fibrosis, respectively.
resultsFeeding with high-fat or GAN diet for 1-4 months repressed hepatic CEACAM1 expression in wild-type but not KI mice. Mutating PPRE-RXRα prevented diet-induced impairment of insulin clearance to maintain normoinsulinemia and insulin sensitivity. High-fat diet failed to reduce energy expenditure and spontaneous locomotor activity in KI, as it did in wild-type mice. GAN feeding for 4 months caused mounting of a Th1-inflammatory response and hepatic fibrosis in wild-type but not KI mice.
conclusionsBlocking CEACAM1 repression while maintaining endogenous regulatory mechanisms and normal physiologic conditions sufficed to curb diet-induced metabolic dysregulation, steatosis, energy imbalance, and MASH progression.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.